News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Insider Monkey11h agoneutral
Johnson & Johnson (JNJ): Limited Analyst Upside, but Management Sees a Clearer Path to Growth24/7 Wall St.2d agoneutral
4 Dividend Raisers With Balance Sheets Strong Enough to Keep Raising Through Any DownturnGuruFocus.com2d agoneutral
State Street Health Care SPDR (XLV) Adds Eli Lilly and J&J on Nov. 4MT Newswires2d agoneutral
Johnson & Johnson Gets FDA Accelerated Approval for Head and Neck Cancer DrugACCESS Newswire3d agoneutral
Protagonist Reports Third Quarter 2026 Financial Results and Provides Corporate Update24/7 Wall St.3d agoneutral
4 Dividend Kings That Could Pay You for the Rest of Your RetirementPharmaceutical Technology3d agoneutral
Big pharma-backed T-Therapeutics snags $133m to bring TCEs to clinic24/7 Wall St.3d agoneutral
3 Dependable Dividend Stocks for a $250,000 Passive Income Strategy